Expression of ALDH1A1, ALPL, ITGA6, CD44, PROM1 (CD133), LGR5, and YAP1 upregulated in the E2 and E3 phenotypes was consistent with cancer hallmarks including cell plasticity, self-renewal, and drug-tolerant persistence [68,121–126]. Here, CD44 is linked to cancer.